Starling Oncology, Inc. Stock Repurchased and Retired During Period, Value
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Starling Oncology, Inc. stock repurchased and retired during period, value for the quarter ending 2022-06-30 was $9.00M.
- Starling Oncology, Inc. stock repurchased and retired during period, value for fiscal 2022 was $9.00M.
| Period end | Stock Repurchased and Retired During Period, Value 3 month | Stock Repurchased and Retired During Period, Value 12 month |
|---|---|---|
| 2022-12-31 | $9.00M 10-K · filed 2024-03-28 | |
| 2022-06-30 | $9.00M 10-Q · filed 2023-11-08 |